Northwest Biotherapeutics (NWBO) EBT Margin Growth (3y) (2013 - 2026)
Northwest Biotherapeutics (NWBO) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Northwest Biotherapeutics | 253,653.43 | -1.53 Mn | - | -109,149.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109,149.00 |
| Dec 31, 2025 | 85,758.00 |
| Sep 30, 2025 | 5.48 Mn |
| Jun 30, 2025 | -1.42 Mn |
| Mar 31, 2025 | -152,262.00 |
| Sep 30, 2024 | -139,914.00 |
| Jun 30, 2024 | -58,120.00 |
| Mar 31, 2024 | 271,555.00 |
| Dec 31, 2023 | 136,273.00 |
| Sep 30, 2023 | 2.09 Mn |
| Jun 30, 2023 | 42.44 Mn |
| Mar 31, 2023 | -10,603.00 |
| Dec 31, 2022 | -271,871.00 |
| Sep 30, 2022 | -6.20 Mn |
| Jun 30, 2022 | -344,568.00 |
| Mar 31, 2022 | -100,698.00 |
| Sep 30, 2021 | -91,994.00 |
| Jun 30, 2021 | 533,291.00 |
| Mar 31, 2021 | 40,325.00 |
| Dec 31, 2020 | 4.06 Mn |